|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | ||
| Depreciation | ||
| Stock-based compensation | ||
| Change in fair value of warrant liability | ||
| Gain on asset disposal | ||
| Amortization of operating lease right-of-use assets | ||
| Net accretion and amortization in marketable securities | ||
| Loss on extinguishment of debt | ||
| Amortization of debt issuance costs | ||
| Amortization and write-off of debt issuance costs | ||
| Other non-cash items | ||
| Changes in operating assets and liabilities: | ||
| Accounts receivable, net | ||
| Prepaid expenses and other assets | ||
| Accounts payable | ||
| Accrued expenses and other liabilities | ||
| Operating lease liabilities | ||
| Deferred revenue | ||
| Deferred rent | ||
| Other assets | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities: | ||
| Purchases of property and equipment | ||
| Purchases of marketable securities | ||
| Proceeds from maturities of marketable securities | ||
| Net cash provided by (used in) investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds from issuance of common stock in public offering, net of underwriting discounts and offering costs | ||
| Proceeds from issuance of convertible preferred units, net of issuance costs | ||
| Proceeds from debt financings, net of debt issuance costs | ||
| Repayment of term loan | ||
| Payments of Series C issuance costs | ||
| Proceeds from issuance of common stock upon exercise of stock options | ||
| Payments of debt issuance costs | ||
| Payments on capital lease obligations | ||
| Payments for tax distributions | ||
| Net cash provided by financing activities | ||
| Net increase in cash, cash equivalents and restricted cash | ||
| Cash, cash equivalents and restricted cash at beginning of period | ||
| Cash, cash equivalents and restricted cash at end of period | ||
| Supplemental non-cash operating information: | ||
| Right-of-use assets obtained in exchange for lease liabilities | ||
| Interest paid on term loan | ||
| Supplemental non-cash investing and financing information: | ||
| Property and equipment additions included in accounts payable and accrued liabilities | ||
| Issuance costs for convertible preferred units included in accounts payable and accrued liabilities | ||
| Public offering costs included in accounts payable and accrued liabilities | ||
| Stock option exercise proceeds included in prepaids and other current assets | ||
| Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets: | ||
| Cash and cash equivalents | ||
| Restricted cash |
Loading...